Tecnifar is a company that looks at the pharmaceutical market with a different view: where others see healthcare, Tecnifar sees life! More than answering the industry challenges, the agents’ expectations and the populations’ needs, Tecnifar tries to have an active role in improving the quality of life of Portuguese people. Tecnifar is a reference amongst Portuguese companies in the healthcare sector, with increasing international acknowledgement. The first steps were taken together with the Luso-Fármaco Institute and Medicamenta, companies with which it shared synergies from 1969 – when it was founded – to 1986. From that year on, Tecnifar won total autonomy and started the adventure of growing by itself, with independence, confidence, and determination. It is a family company since its foundation, with 100% national capital. Tecnifar path has been as dynamic as sustained because its growing strategy was always well established in precision and innovation criteria – the same criteria that guide its position and activity. Tecnifar works in the pharmaceutical sector producing, selling, and distributing medical products, including their own drugs and patented products from research companies of renowned expertise such as Angelini, Desitin, J. Uriach, Menarini, MSD, Ferring, Teva, Almirall and Medinfar. The active and constant search for the best therapeutic solutions made its portfolio even more complete, having today a wide offer of prescription medicinal products, OTC’s and medical devices for treatments related to the central nervous system, cardiovascular system, respiratory, urology, allergology and rheumatology areas among others.
| Website | https://www.tecnifar.pt |
| Revenue | $100 million |
| Employees | 89 (68 on RocketReach) |
| Founded | 1969 |
| Address | Rua José da Costa Pedreira, Nº11B - TORRE SUL, Lisboa, Lisboa 1750-130, PT |
| Phone | +351 21 033 0700 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+9 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Hospitals & Clinics, Healthcare |
| Web Rank | 6 Million |
| Keywords | Pharmaceutical, Healthcare, Biotechnology, Drugs, Life Sciences, Clinical Trials, Drug Development, Medical Devices, Health Technology, Biomedical, Pharmacy, Healthcare Solutions, Pharmaceutical Manufacturing, Medical Research, Health, Therapeutics, Patient Care, Innovation |
| Competitors | Roche, Novartis, The Janssen Pharmaceutical Companies of Johnson & Johnson, Sandoz, Cipla, Galp, Arkopharma, Hovione, BIAL, Grupo Medinfar +50 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 806 Companies |
| NAICS | NAICS Code 622 Companies, NAICS Code 6221 Companies, NAICS Code 62 Companies |
Looking for a particular Tecnifar employee's phone or email?
The Tecnifar annual revenue was $100 million in 2026.
António Costa is the Group CEO of Tecnifar.
68 people are employed at Tecnifar.
Tecnifar is based in Lisboa, Lisboa.
The NAICS codes for Tecnifar are [622, 6221, 62].
The SIC codes for Tecnifar are [80, 806].